Please note this is an extract of the original bulletin.
Information on how to request assistance from NSDR.
Updated language used from ‘how to report’ to ‘how to request assistance’ to describe the service more accurately.
LFDs have proved vital for detecting SARS-CoV-2 when it is most infectious. This has remained true with new variants including Alpha, Delta and Omicron.
Added ‘Analysis of real-world performance of lateral flow antigen devices in detecting SARS-CoV-2 Omicron variant (B.1.1.529)’, ‘Comparison of manufacturer reported lateral flow device sensitivity with the sensitivity observed in evaluation’, and ‘Testing for SARS-CoV-2 using antigen-detecting lateral flow devices’.